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Abstract
This paper was initiated by a symposium, in which the present authors contributed, organised by 
the International RDC/TMD Consortium Network in March 2013. The purpose of the paper is to 
review the status of biobehavioural research – both quantitative and qualitative – related to 
orofacial pain with respect to the etiology, pathophysiology, diagnosis and management of 
orofacial pain conditions, and how this information can optimally be used for developing a 
structured orofacial pain classification system for research. In particular, we address: 
representation of psychosocial entities in classification systems, use of qualitative research to 
identify and understand the full scope of psychosocial entities and their interaction, and the usage 
of classification system for guiding treatment. We then provide recommendations for addressing 
these problems, including how ontological principles can inform this process.
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1 Introduction
With the notable exception of temporomandibular disorders (TMD), psychosocial factors 
have received scant attention from most research devoted to orofacial pain (OFP) conditions 
(1). The persistent absence of psychosocial factors in OFP research seemingly conveys the 
implicit message that they are unimportant (in comparison to nociceptive processes). 
However, throughout this paper we will highlight and explain the impact of psychosocial 
factors and the influence they exert on how disease courses in OFP evolve. Related to this is 
our relative ignorance of what constitutes the phenotype of a pain condition. The Orofacial 
Pain: Prospective Evaluation and Risk Assessment study (OPPERA) has provided an 
immense amount of data describing the phenotype associated with TMD (for summaries, see 
(2, 3)), but other OFP conditions are less well characterized.
The characterization of OFP conditions must necessarily include attention to psychosocial 
factors and, despite the level of data provided by OPPERA regarding TMD, the question 
remains: what level of (psychosocial) phenotypic data should be collected for the 
characterization of other OFP conditions? Future research identifying the phenotype of other 
OFP conditions could progress along the same, exhaustive, lines as OPPERA or it could 
progress perhaps more pragmatically and efficiently by qualitatively examining the patients’ 
experiences caused by the disorder underlying their pain condition, thereby allowing us to 
develop a more complete set of hypotheses regarding the composition of such phenotypes, 
and the nature of the disorders leading to these phenotypes. This approach may help identify 
specific constructs (or variables) of interest, tie these constructs to anatomical and 
physiological entities, reduce redundant data collection, and explain ‘anomalies’ within 
accepted classifications.
The authors of this paper were invited by the International RDC/TMD Consortium Network 
for a symposium, held at the 2013 IADR General Session in Seattle, in order to review the 
state of the art regarding the formal development of diagnostic criteria for OFP conditions. 
The ultimate aim of this examination was to critically appraise the arguments for and against 
the development of specific Research Diagnostic Criteria for Orofacial Pain (RDC/OFP). 
The domains and perspectives represented by the authors are: OFP conditions, qualitative 
research, behavioural medicine, medical classification and related statistical methods, and 
realism-based ontology . Questions for which answers were sought in this paper included:
1) Are psychosocial constructs identified for TMD useful for orofacial pain?
2) Can qualitative research methods provide significant insights into OFP which 
might affect how we identify entities as well as axes or dimensions for 
diagnostic criteria?
3) Are traditional (conservative) approaches to medical classification sufficient for 
new diagnostic criteria or do they need to be complemented by recent 
developments in the application of ontological realism?
The other parts of this series of papers cover ontological realism in depth (4) and 
biomarkers’ role in an emerging classification system (5). This paper focuses on questions 
one and two above and relates its findings in relation to questions one and two to question 
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three, but an in-depth exploration and explanation of ontology's role can be found in part one 
of this series.
2 The biopsychosocial model of pain
The biopsychosocial model proposed by Engel (6, 7) has been applied to most types of 
chronic pain with parallel improvements in its understanding and management (8-11). 
Alongside the application of this model there have been important advances in our 
understanding of the biological mechanisms behind chronic pain (12-16). It has been 
demonstrated that chronic pain involves multiple systems in addition to the nociceptive 
system. It is this fact that makes classification of OFP conditions so challenging.
Pain conditions undoubtedly vary in the extent to which psychosocial characteristics drive 
the presenting symptom pattern. Drossman (17) suggests a two-dimensional plot on which 
various health conditions, including pain conditions, can be mapped (Figure 1). The axes 
(dimensions) for this plot are disease (biological factors) and illness (psychosocial factors). 
Conditions can, therefore, range from those with a large role for illness factors, for example 
chronic abdominal pain, to those with a large role for disease factors, for example an 
asymptomatic ulcer. Clearly, some conditions can then, therefore, lie in between disease and 
illness in terms of the factors driving the patient's presentation, and it is, of course, this area 
bridging both illness and disease that accounts for the immense difficulties in the 
consultation room. Figure 1 demonstrates one perspective of where OFP conditions such as 
myofascial TMDs or neuropathic orofacial pain conditions may be positioned in this two- 
dimensional space. The suggested locations of myofascial TMDs and neuropathic orofacial 
pain conditions in the plot are not intended to represent a firm consensus in the field. They 
are also not intended to precisely depict the relative impact versus cause of psychosocial 
factors, but rather hypothesized relative placements about the role of illness versus disease 
factors. Indeed, within a certain group of disorders it is likely that specific disorders might 
ultimately occupy different locations in two-dimensional space. For example, a myofascial 
TMD with painful disc interference would likely occupy a location different from that 
currently depicted for “myofascial TMD”.
Despite the preliminary mappings in Drossman's two-dimensional biopsychosocial space, it 
is important to remember that the plotted points represent the likely role of biological and 
psychosocial characteristics for the average person with a given condition. Psychosocial 
characteristics themselves may drive care-seeking for an array of conditions (18) to varying 
degrees. It is therefore important to understand this, the individual patient, and the factors 
that may affect his or her prognosis for a given condition, rather than only the characteristics 
of the hypothetical ‘average’ patient. The assessment and understanding of the individual 
patient with orofacial pain therefore requires the inclusion of psychosocial information. The 
‘average’ patient profile only provides an indication of whether a patient is statistically 
likely to be at risk of psychosocial burden.
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2.1 Should an orofacial pain classification be based on the biopsychosocial model of 
pain?
It is the inclusion of the biopsychosocial model that is perhaps what most distinguishes the 
RDC/TMD from other classification systems of pain in general. The RDC/TMD explicitly 
includes separate assessment and classification for psychosocial functioning on a 
psychosocial “Axis II,” orthogonal to signs and symptoms that lead to primary physical 
disorder classification in exactly the same manner as Drossman proposes. Should, therefore, 
an expanded orofacial pain classification system formally include a similar psychosocial 
assessment intended for all patients with such complaints? The short answer is: Yes. The 
longer answer involves an understanding of the evolving view of TMDs and the 
biopsychosocial model.
The use of a dual axis system was included in the RDC/TMD because of awareness of the 
biopsychosocial nature of virtually every chronic pain condition, including but not limited to 
TMDs. Axis II instruments were selected to screen patients for psychological status 
(depression and nonspecific physical symptoms) and to classify patients into a “chronic pain 
grade” based on characteristic pain and activity interference levels from the Graded Chronic 
Pain Scale (GCPS) (19, 20). These Axis II measures were intended to serve as screening 
instruments for the constructs of depression, somatic symptoms, and disability, given their 
relevance as risk factors for poor clinical outcomes as based on the data available at that 
time. By identifying patients at risk of poor outcome due to impaired psychosocial 
functioning, the intent of such screening was that these individuals could be referred for 
psychological assessment and interventions. Data since the publication of the RDC/TMD 
have only reinforced the significance of psychosocial factors in treatment response (21-23) 
at least with respect to improved psychosocial function. Tailoring treatment to patients with 
compromised psychosocial adaptation has been increasingly shown to be effective (22). 
Ongoing development of the RD/TMD has resulted in the recent publication of the 
DC/TMD (24), which maintains the dual axis structure and focus of the parent criteria, but 
attempts to improve validity and reliability of Axis I by building on the RDC/TMD 
validation project data (25-30). The DC/TMD has also revised the Axis II to allow a 
shortened version for everyday clinical practice and full details can be found at the 
RDC/TMD Consortium's website (http://www.rdctmdinternational.org/
TMDAssessmentDiagnosis/DCTMD.aspx).
Documentation of psychosocial dysfunction in orofacial pain conditions other than TMDs 
has been much less extensive. Does that mean that psychosocial factors are not emerging 
from the data as prognostic factors for other orofacial pain conditions, or does that mean that 
psychosocial factors have yet to be systematically evaluated? The biopsychosocial model of 
pain remains the primary justification for the assessment of psychosocial factors in all 
orofacial pain conditions and pain conditions in general. What then has been the frequency 
with which Axis II psychosocial assessments have appeared in the research literature? 
Limiting our review to English-language research articles retrievable through PubMed 
including abstract terms of temporomandibular joint disorder or temporomandibular pain 
and dysfunction syndromes or TMD, and abstract words of patient(s) and RDC, we recently 
found the following: in 2012 alone, 43 clinical research articles met search criteria by 
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reporting results of RDC/TMD Axis I to identify and characterize patients, but only 20 of 
these reported some aspects of RDC/TMD Axis II assessment (31). It might be argued that 
some authors assessed RDC/TMD Axis II but did not report results in a particular 
manuscript. If this is the case we would suggest that this leaves the reader unable to assess 
the effect of psychosocial heterogeneity within the sample on the outcome of an 
intervention. This may be one of the reasons why outcomes for similar interventions differ 
markedly, even when Axis I physical diagnoses are identical between studies.
Nearly a decade ago, an extensive review (32) documented the comorbidity between 
depression and pain, noting their shared biological pathways. Moreover, the review 
documented that, for a variety of pain conditions, comorbid depression was associated with 
long-term negative outcomes including functional disability, chronicity, greater use of health 
care resources, and poorer adherence to prescribed treatment modalities. Consequently, the 
focus on psychosocial factors in pain patients has been considered primarily from a ‘yellow 
flag’, or risk, perspective in which psychosocial factors affect prognosis (e.g., (33)). As 
psychosocial pain research continues to be successful in identifying constructs that affect 
pain experience as well as developing better measures of those constructs, pain treatment 
should benefit from the inclusion of therapies that strive to target those constructs. 
Psychosocial pain treatment overall is, however, at a standstill, given the number of 
identified relevant constructs versus treatments with demonstrated efficacy. We believe that 
this represents an opportunity to more carefully evaluate how these constructs should be 
considered within the context of classification, in order for the disorders to be better 
conceptualized with respect to treatment models.
Less empirical emphasis has been paid to psychosocial factors as treatment effect modifiers 
or moderators, or as treatment mediators. Psychosocial factors as treatment effect 
moderators would be indicated if a particular treatment had a differential effect in the 
presence of specific psychosocial risk factors. A few notable constructs – fear–avoidance, 
depression, anxiety, and pain-catastrophizing – exhibit strong models that explain behavioral 
or CNS mechanisms linking the identified psychosocial construct with pain intensity or 
persistence. The empirical support for the success, in terms of pain response, of an 
intervention specific to the respective identified aforementioned constructs is not strong, 
however, because psychosocial treatments are generally provided as a “package” with 
multiple potential modes of action. Aside from a few exceptions (34-36), psychosocial 
factors as treatment effect moderators in pain interventions have been under-examined. 
Moreover, many studies are often underpowered to detect moderator effects. To the extent 
that psychosocial factors are or can be identified as moderators, they may help clinicians to 
answer the question of “what psychosocial intervention works best for whom?” (37). To our 
knowledge, only one randomized controlled clinical trial (38) has shown that more intensive 
psychosocial interventions can benefit psychologically high risk patients with 
musculoskeletal pain, while simpler interventions may benefit lower risk patients. Despite 
the persuasive hypothesis that matching treatments to patient's biopsychosocial 
characteristics should improve outcome (39) and efficient care, a recent meta-analytic 
review (35) concludes that evidence of moderator effects and benefit of targeting treatments 
in chronic pain patients is currently not strong. On the other hand and from a different 
perspective, studies specifically examining TMD patients (22) suggest that simple self-care 
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strategies may be sufficient for psychosocially functional patients, but that impaired patients 
benefit from more comprehensive treatment including cognitive behavior therapy.
3 Qualitative research is a useful tool to identify psychosocial entities to be 
represented in future orofacial pain classifications
3.1 Characteristics of qualitative research
Qualitative research (QR) seeks not to enumerate, but to interpret, and build understanding 
of naturally occurring phenomena from the perspective of the participants (40, 41). To give 
an example, one might examine the “objective” pain levels of patients undergoing 
neurosurgery for trigeminal neuralgia (quantitative), but one might also be interested in the 
factors that drive their desire to undergo such a procedure and their experiences pre- and 
post-operatively (qualitative). QR can be used in a standalone study, or in combination with 
quantitative research (42), for example to define the new items required for a new health 
status measure (an example in orofacial pain is provided by Durham et al (43)), or to help 
explain unusual or complex results from a quantitative survey.
Data are usually collected in QR by the use of any of four main methods: interviews, focus 
groups, observation, or documentary analysis (41, 44-46). In-depth summaries of the 
differences between qualitative methods and their differences to quantitative research 
methods are available (40, 41).
Subject samples in qualitative research tend to be small, non-probabilistic, and purposive 
aimed at identifying a depth and breadth of opinion (47). If the study is of a responsive 
design the sample will also evolve in order to identify any groups of individuals who might 
give disconfirming evidence of any theory that has been generated.
The natural occurring data “unit” of qualitative research is text. This text can be generated 
from observations, interviews or focus groups, or it can be directly analyzed from patient 
submissions (47). The text collected is subject to a coding process (48, 49) whereby the 
researcher systematically analyses the text at several different levels for recurring themes, or 
experiences, expressed by participants. From this the data can start to be organized into 
recurring units and (nascent) theoretical constructs and explanations can be developed in 
line with the applicable typologies, theoretical paradigms, and philosophical assumptions 
(50). Wolf et al give a worked example of one approach to coding relevant to chronic 
orofacial pain (51, 52).
The validity of QR has often been a source of concern for quantitative trained clinical 
researchers, but there are several simple strategies to help ensure the validity of the data and 
the theory generated in a qualitative study. These strategies include: independent assessment 
of transcripts (dual coding by independent researchers); data-rich papers or appendices so 
that readers are able to read in full relevant portions of the data collected; and triangulation 
of data/theory by other methods (53-56).
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3.2 Assessment of psychosocial factors in orofacial pain using qualitative research
There has been a slowly increasing awareness of the benefits that qualitative research can 
bring to the examination and understanding of the psychosocial dimension of chronic pain 
(57, 58).
A brief literature search using PubMed and Web of Science was undertaken in February 
2013 to identify relevant papers in the field from 1950 onwards. Table 1 demonstrates the 
number of hits and the search terms employed. The a priori exclusion criteria for a paper 
were: 1) the paper was not in the English language; 2) the paper did not primarily focus on a 
named orofacial pain condition; or 3) the paper focused on professional perceptions rather 
than patient perceptions.
Abstracts were read for all 165 identified papers, of which 147 were original research 
papers. Of these 147, only 15 had an orofacial pain condition as the primary focus of the 
study (43, 51, 52, 59-70). Of these 15 papers, 2 involved some element of professional 
perceptions (61, 66), and the remaining 13 papers provide us with some data (43, 51, 52, 59, 
60, 62-65, 67-70).
When the 13 papers were read carefully it was apparent that some authors had reported 
linked data in two papers (43, 51, 52, 62, 64, 65), with only 10 original qualitative reports 
available regarding orofacial pain conditions: toothache, temporomandibular disorders 
(TMDs), persistent dentoalveolar pain, and nonspecific chronic orofacial pain. Table 2 
summarizes the studies’ characteristics and Table 3 outlines their quality assessment 
according to Popay et al and the qualitative research appraisal tool (55, 71). Interestingly, 
contrary to a recent report about the general state of qualitative research in dentistry (72) the 
quality assessment was reasonably high for papers specific to an orofacial pain condition. 
This finding should, however, be interpreted with caution as the assessment was performed 
by only one researcher.
All 13 papers were read, and common and recurring themes or experiences were extracted 
from them. This was done across all papers irrespective of pain condition and also by 
condition for TMDs and “toothache”. It should be noted at this point that this process was 
for descriptive purposes only and cannot be considered to be a qualitative metasynthesis for 
two critical reasons: the methodologies vary between studies, and the data are too sparse and 
divergent to allow this at present. We wish here to only illustrate the value of the process 
with respect to the goals of this paper, which is to provide a rich description of orofacial 
pain in order to better serve purposes of developing classification.
Temporomandibular disorders clearly exemplify the difficulties of radiating pain, which 
tends to pervade into everyday activities (43, 62, 65, 67). The psychosocial impacts reported 
across those studies examining TMDs included: embarrassment when eating outside of the 
home reportedly because of clicking and locking and changes to dietary intake/consistency 
(43, 67); generalized reduced functional ability (43, 62, 67); relationship effects reportedly 
mediated both by mood changes and by decreased willingness to be intimate (43, 65, 67); 
negative mood changes seemingly because of the persistency of the problem and lack of 
diagnosis (43, 65, 67, 70); reduction in ability to perform in normal employment/school (43, 
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65, 67); and a degree of helplessness implicitly caused by the unremitting nature of the 
complaint (43, 65, 67). Another key defining feature reported by some of the studies in 
TMD was the uncertainty individuals faced when looking for a diagnosis and the lack of 
legitimacy they often felt in their care-seeking (43, 62, 65). This uncertainty then had 
consequences for how individuals felt they were supported by close friends and relatives. 
These feelings around uncertainty and legitimacy were mirrored in the papers examining 
“non-specific chronic orofacial pain” as were the extensive day-today limitations in activity 
(51, 52).
“Toothache” seemed to be reported as an acute, and easily conceptualized, problem in the 
studies examining it (59, 60, 68, 69). “Toothache” could present suddenly as an intense pain, 
or build gradually to a peak of intensity, but in either case a level of “unbearable” pain was 
often the trigger to seek care (59, 60, 68, 69). Psychosocial impacts of “toothache” were 
extremely varied, but those that recurred included: general activity limitation including 
decreased work productivity (59, 60, 68, 69), sleep disruption (59, 60, 69), and changes in 
dietary intake which were either abstinence from eating, or changes in consistency of intake 
(59, 60).
Examining across all orofacial pain conditions it would appear, based on the qualitative 
research, that there are some common biopsychosocial impacts to all orofacial pain 
conditions:
• Perceived sleep disturbance
• Activity limitation – social and work
• Changes in dietary choice and consistency
• Distress
• Decreased self-efficacy
Qualitative research in chronic orofacial pain has also led to further developments in 
understanding chronic orofacial pain including the possibility of a liminal state between 
health and illness in chronic orofacial pain (62) and its consequences. Qualitative research 
techniques have also allowed the development of putative screening instruments for the 
more rare conditions such as Persistent DentoAlveolar Pain disorder (PDAP) (63) grounded 
in the patients’ experiences.
Unsurprisingly this review appears to demonstrate a large number of psychosocial impacts 
in the chronic conditions as compared to the acute and “curable” toothache conditions. 
There are also clear implications for the sociology of chronic orofacial pain to be examined 
in more depth given the expressed problems in obtaining legitimacy and thereby receiving 
social support for the individual's complaint. More research is required to assess the effect of 
psychosocial factors as treatment moderators or mediators for orofacial pain (73) (p.423). 
Qualitative research, if appropriately performed, clearly has potential to not only elucidate 
factors that play a role in outcome, but also explain how they may do so.
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4 Phenotype determination using the Ontology of General Medical Science
4.1 Disorders, diseases, and disease courses
The Ontology of General Medical Science (OGMS) is based on a terminological framework 
that encompasses diseases, their causes and manifestations, and diagnostic acts and other 
entities pertaining to the ways diseases are recognized and interpreted in the clinic. The 
framework was designed to avoid the common problem of entities (for example disease) and 
evidence for the existence of entities becoming inextricably joined (conflation of entity and 
evidence for entity) and mutually exclusive so that one wrongly would assume that the 
disease does not exist unless a particular sign or symptom (evidence) exists (74). Clearly, 
however, the disease can exist irrespective of whether the sign or symptom is present, and 
the opposite is also true: the sign or symptom may be present but the disease that the 
clinician has in mind may not be in existence in the individual with the sign or symptom.
The basic axiom of the OGMS is that every disease rests always on some (perhaps as yet 
unknown) physical basis. When, for example, there is in a specific patient an elevated level 
of TNF in the synovial fluid of the TMJ, then this is because some physical structure or 
substance in the organism is disordered, for instance physical damage of some sort in the 
TMJ. It is this physically damaged, ‘abnormal’, structure or substance that is known in 
realist ontology jargon as the ‘disorder’. This use of the term ‘disorder’ is thus narrower 
than the loose manner in which the term is used in medical jargon where typically no 
systematic distinction is made between ‘disorder’ and ‘disease’.
OGMS states that when such a disorder exists in the organism (human body in this case) 
then there is a second entity present known as disposition. Dispositions are just like, for 
example, functions, tendencies and propensities and are therefore special types of realizable 
entities. The use of the term ‘realizable’ in relation to the entity refers to the fact that there 
must be certain circumstances for a disposition to be realized. What, for instance, we would 
call “pain on palpation of the Temporomandibular joint (TMJ)”, is the realization of such a 
disposition, namely of the disposition to report pain when palpating the TMJ: the patient will 
only report pain on palpation when brought under suitable conditions such as sufficient 
presence of TNF (75). A patient without such levels of TNF would still have the disposition, 
but not the realization thereof. Similarly, if there is in some body part or organism a 
disorder, then there is in that organism also the disposition for the organism to act or 
undergo processes in a certain abnormal way. It is this disposition that in realist ontology 
jargon is called the disease. For OGMS, disease and disorder are thus two distinct entities, 
but tied together like the two sides of a coin: one cannot exist without the other. In case of 
TMD, the disorder might be, for instance, a displaced disk or arthrosis in the TMJ, and the 
corresponding disease then the disposition for pathological processes leading to clicking, 
pain, limited mobility, etc. From the point of view of OGMS, a term like ‘TMD’ is thus 
ambiguous as OGMS recognizes Temporomandibular Disorder and Temporomandibular 
Disease as distinct entities.
It is only when the disease leads to pathological processes (e.g. inflammation) that then a 
third entity comes into existence: the disease course which is formed by all processes of 
involved body parts, including the entire organism, which realize the disposition. The 
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disease course includes manifestations that can be recognized as symptoms and signs of the 
disorder (e.g. pain, crepitus, decreased mobility) or through measurement assays (e.g. 
laboratory tests, imaging procedures).
4.2 Disease courses and illnesses
The OGMS view remains valid for the patient with mental and psychological issues as 
exemplified in the Ontology of Mental Disease (76). As an example, certain forms of 
depression are characterized by morphologic configurations in specific brain regions that 
differ from the configurations exhibited by healthy individuals such as, for instance, 
abnormal configurations in or of the serotonin receptors. These configurations thus 
constitute the disorder in OGMS sense. With this disorder at the level of serotonin receptors 
then comes the particular disposition for the individual to act in a certain manner commonly 
recognized as depressive mood and vegetative symptoms. It is this disposition that 
constitutes the disease that we call ‘depression’. This disposition may then become realized 
in pathological processes of various sorts for example, disturbed sleeping or altered behavior 
characterized by a decrease in certain activities. Other pathological processes are those 
which are part of the disease course which together constitute the more complex process 
described as ‘distress’ or ‘mental suffering’.
4.3 Towards a phenotype for orofacial pain conditions
OGMS offers three classes which are useful to be included – and further to be subtyped – in 
an ontology-based classification system for orofacial pain conditions:
• Phenotype – A (combination of) bodily feature(s) of an organism determined by 
the interaction of its genetic make-up and environment.
• Clinical Phenotype – A clinically abnormal phenotype.
• Disease Phenotype – A clinical phenotype that is characteristic of a single disease
Entities that qualify as bodily features are: (1) physical components such as bodily 
components (e.g., nerve cells, nociceptors, neurotransmitters) and external components (e.g., 
pathogens, toxins, microbiome); (2) bodily qualities such as cytokine concentrations; (3) 
bodily processes in which physical components participate, irrespective of them being 
normal (e.g., neurotransmission and concordant pain sensation), pathological (e.g., phantom 
pain), or induced through interventions (e.g. hyperesthesia).
Examples of bodily processes that qualify as clinical phenotypes are the aforementioned 
disturbed sleeping and distress in the meaning of mental suffering. Sleeping and brain 
processes such as thinking and decision-making are phenotypes determined by the 
interaction of our genetic make-up and environment. In contrast disturbed sleeping and 
distress are clinically abnormal in the sense that they are: (a) not part of the life plan for an 
organism of the relevant type (unlike pregnancy or menopause), and (b) causally linked to 
an elevated risk of pain, of other feelings of illness, or of death or dysfunction, such that the 
elevated risk exceeds a certain threshold level (74). Disturbed sleeping and distress therefore 
qualify further as clinical phenotypes.
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A phenotype, either disease or clinical phenotype, can exist without being observed. With 
the advance of technology, the ability to detect more underlying components will expand. 
The clinical phenotype – for a specific patient – incorporates the abnormal phenotypes 
realized at each stage of the disease course. A disease phenotype may be a single type of 
abnormality characteristic of a given disease; or it may be a combination of several 
manifestations of a disease and clinically normal physical components, ordered in a 
temporal sequence characteristic of one or more typical disease courses for the given 
disease.
OGMS has been used as a foundation for a series of domain-specific ontologies three of 
which will be described in order to provide initial evidence that using such classifications 
for unproven domains such as orofacial pain may contribute to better understanding of 
orofacial pain and, in particular, the psychosocial domain. The Neurological Disease 
Ontology (ND) is an extension of OGMS that provides a set of classes to represent 
neurological diseases along with their associated signs and symptoms, assessments, 
diagnoses, and interventions encountered in the course of clinical practice and research (77). 
Initial work on ND was focused on the areas of dementia and Alzheimer's disease, multiple 
sclerosis, and stroke and cerebrovascular disease.
The Ontology of Adverse Events (OAE) was developed to standardize and integrate data 
relating to adverse events arising subsequent to medical interventions, as well as to support 
computer-assisted reasoning. OAE has over 3,000 terms classified in terms of OGMS, the 
term ‘adverse event’ thereby denoting a pathological bodily process in a patient that occurs 
after a medical intervention. OAE covers adverse events based on anatomic regions and 
clinical outcomes, including symptoms, signs, and abnormal processes. It has been used in 
the analysis of several different sorts of vaccine and drug adverse event data, for example, to 
analyze vaccine adverse events associated with the administrations of different types of 
influenza vaccines and to represent and classify the vaccine adverse events cited in package 
inserts of FDA-licensed human vaccines in the USA (78).
The Infectious Disease Ontology (IDO) consists of a core ontology (IDO Core) covering 
terms and relations generally relevant to the infectious disease domain, and a set of disease- 
or pathogen-specific ontologies developed as extensions from the core. The core IDO 
imports terms such as “disease”, “disorder”, “disease course”, and “treatment” from OGMS, 
and provides infectious disease-specific terms such as “pathogen”, “vector”, “herd 
immunity”, “fomite”, “virulence”, “focal infection”, “carrier”, “seroprevalence”, 
“epidemic”, and “antibiogram” (79).
The examples provided demonstrate that the OGMS is well accepted in a variety of 
biomedical domains. Within the domain of pain, OGMS was first used to give an 
ontologically adequate framework of pain and of other pain-related phenomena (80), 
building on the definition of pain provided by the International Association for the Study of 
Pain (IASP). This framework was then used to develop an ontology-based taxonomy for 
disorders that manifest themselves through the symptom of chronic orofacial pain and are 
commonly seen in clinical practice and difficult to manage (81). The diagnostic criteria 
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proposed using this methodology were then used to conduct a systematic review to identify 
reliable somatosensory evaluation methods for atypical odontalgia patients (82).
OGMS thus offers an ideal framework to categorize the various phenotypes associated with 
differing pain conditions in function of bodily features and their relationship to known 
disease types. Whether the use of such ontologies can improve prognosis or better tailor 
treatment – which would be an ultimate goal in terms of utility – cannot be determined until 
better classification has been developed and then tested.
5 Recommendations
There is no doubt that future orofacial pain classifications need to include representations for 
various types of psychosocial entities. Such entities have been demonstrated to play various 
important roles in the prognosis of pain conditions in general and temporomandibular 
disorders in particular; moreover, psychosocial entities are core components of emerging 
concepts of chronicity (83). However, such entities are not at present systematically 
included in case reports and research studies of other types of orofacial pain. It is here that 
qualitative research can be used in a systematic manner to help identify and explore any new 
psychosocial factors and or phenotypes that have yet to be identified and explored in 
orofacial pain conditions. These may then go on to be represented in future orofacial pain 
classifications using the framework offered by the Ontology of General Medical Science is a 
guide for achieving consistency and coherence.
There are some limited qualitative data available from which it is possible to begin to build 
an understanding of some of the impacts of orofacial pain conditions – to understand the 
lived meaningfulness of the psychosocial entities and why they matter if our classification 
system is to truly capture the depth and breadth of the pain experience. Despite a slight 
increase in the publication of qualitative studies in the last decade, such studies still tend to 
be sporadic and somewhat uncoordinated in their approach to exploring the biopsychosocial 
complexities of orofacial pain. Perhaps given recent endorsement from major funding bodies 
(84) this will change, but a more coordinated and targeted examination of the conditions 
comprising orofacial pain is urgently needed. This will ensure that advances in patient 
management remain grounded in the patients’ expectations and address the problems that 
they are experiencing (85). It will also aid the incorporation of the full scope of the 
respective psychosocial entities identified to be adequately and comprehensibly represented 
in a classification system
Simultaneous with incorporation of psychosocial entities into a developing classification 
system is the application of some of those entities in the clinic setting. If psychosocial 
assessment is not considered a key characteristic in which TMD patients in research studies 
are described, how likely is it that such characteristics will be assessed in studies on other 
orofacial pain patients? How much less likely is it that psychosocial characteristics will be 
routinely assessed in clinical practice of TMDs or other orofacial pain conditions? This 
paper intends to rectify the lack of attention to psychosocial factors: routine psychosocial 
assessment of orofacial patients is an inherent part of a biopsychosocial model of care. 
Given the potential utility of psychosocial factors for reconciling disparate research findings 
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and the potential of psychosocial factors to guide proper treatment for individual patients 
and predict prognosis, we suggest that a good argument is needed to not screen for 
psychosocial factors in orofacial pain patients. For the orofacial pain clinician, the primary 
role of assessment for psychosocial factors is likely, therefore, to involve their role in 
predicting patient prognosis and, potentially, the need to refer the patient for specialty 
psychological or psychiatric care to treat comorbid psychosocial problems. An ontological 
realism-based taxonomy places the elements that need to be addressed in such an assessment 
in perspective, and an ontological realism-based taxonomy reduces thereby the possibility 
for incomplete documentation or misinterpretation thereof afterwards.
In summary therefore the recommendations of this review are:
1. Use qualitative research to systematically identify and explore any new 
psychosocial factors and or phenotypes in orofacial pain.
2. Take a coordinated and targeted approach to future qualitative research in orofacial 
pain in order to examine the biopsychosocial impact of orofacial pain conditions.
3. Adopt the framework offered by the Ontology of General Medical Science to build 
future orofacial pain classifications, using data gathered from point 1 above and 
other sources as appropriate, that intrinsically include psychosocial factors as one 
necessary part of how pain would be classified.
4. Apply the knowledge gained through research into psychosocial phenotypes into 
everyday clinical practice both through routine screening for psychosocial 
comorbidities and appropriate (liaison for) management of these comorbidities.
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Figure 1. Illness versus disease. Adapted from Drossman (1998)
Traditional bi-axial depiction of Disease vs Illness using estimated typical placement of 
representative conditions. Adapted from Drossman, 1998.
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Table 1
Search strategy and numbers of papers identified
Qualitative
AND Dental Dentistry Oral Orofacial Facial
1967 1236 3153 26 373
AND
pain 11 12 126 1 15
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